Genetic Testing Utilization: Discrepancies Between Somatic and Germline Results in Patients With Cancer Reviewed at the UW Health Precision Medicine Molecular Tumor Board.
Isaac P HornAnna L ZakasKelcy J Smith-SimmerLaura E BirkelandRachel SundstromMark E BurkardJennifer M WeissPublished in: JCO precision oncology (2024)
This study highlights the differences in genetic testing types and demonstrates that conducting germline testing at earlier stages of diagnoses is necessary to identify potentially actionable and treatment-specific variants in patients with cancer.